These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 10227432)
1. Benefits of accelerated hyperfractionation for head and neck cancer. Cummings BJ Acta Oncol; 1999; 38(2):131-6. PubMed ID: 10227432 [TBL] [Abstract][Full Text] [Related]
2. Altered fractionation in the management of head and neck cancer. Ang KK Int J Radiat Biol; 1998 Apr; 73(4):395-9. PubMed ID: 9587077 [TBL] [Abstract][Full Text] [Related]
3. Altered fractionation trials in head and neck cancer. Ang KK Semin Radiat Oncol; 1998 Oct; 8(4):230-6. PubMed ID: 9873100 [TBL] [Abstract][Full Text] [Related]
4. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Fu KK; Pajak TF; Trotti A; Jones CU; Spencer SA; Phillips TL; Garden AS; Ridge JA; Cooper JS; Ang KK Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):7-16. PubMed ID: 10924966 [TBL] [Abstract][Full Text] [Related]
5. Randomized trials on altered fractionation in head and neck cancer radiotherapy with conventional fractionation as control arm: another lap to go. Olmi P; Fallai C Tumori; 1998; 84(2):160-6. PubMed ID: 9620240 [TBL] [Abstract][Full Text] [Related]
6. Compliance to the prescribed dose and overall treatment time in five randomized clinical trials of altered fractionation in radiotherapy for head-and-neck carcinomas. Khalil AA; Bentzen SM; Bernier J; Saunders MI; Horiot JC; Van Den Bogaert W; Cummings BJ; Dische S Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):568-75. PubMed ID: 12573743 [TBL] [Abstract][Full Text] [Related]
7. Altered fractionation in radiation therapy for squamous-cell carcinoma of the head and neck. Mendenhall WM; Parsons JT Cancer Invest; 1998; 16(8):594-603. PubMed ID: 9844620 [TBL] [Abstract][Full Text] [Related]
8. Fractionation sensitivities and dose-control relations of head and neck carcinomas: analysis of the randomized hyperfractionation trials. Stuschke M; Thames HD Radiother Oncol; 1999 May; 51(2):113-21. PubMed ID: 10435801 [TBL] [Abstract][Full Text] [Related]
9. A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck. Budach W; Hehr T; Budach V; Belka C; Dietz K BMC Cancer; 2006 Jan; 6():28. PubMed ID: 16448551 [TBL] [Abstract][Full Text] [Related]
10. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard-fractionation radiotherapy for head-and-neck squamous cell carcinomas: first report of RTOG 9003: in regard to Fu et al. IJROBP 2000;48:7-16. Actuarial estimates of late normal-tissue effects...now! Dubben HH; Beck-Bornholdt HP Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):563. PubMed ID: 11579925 [No Abstract] [Full Text] [Related]
11. In regard to Staar et al.: Intensified hyperfractionated accelerated radiotherapy limits the additional benefits of simultaneous chemotherapy-results of a multicentric randomized German trial in advanced head-and-neck cancer. IJROBP 2001;50:1161-1171. Grabenbauer GG; Sauer R Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):300. PubMed ID: 12183004 [No Abstract] [Full Text] [Related]
12. Status of accelerated fractionation radiotherapy in head and neck squamous cell carcinomas. Bourhis J; Wibault P; Lusinchi A; Bobin S; Luboinski B; Eschwege F Curr Opin Oncol; 1997 May; 9(3):262-6. PubMed ID: 9229149 [TBL] [Abstract][Full Text] [Related]
13. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09. Fu KK; Clery M; Ang KK; Byhardt RW; Maor MH; Beitler JJ Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):589-97. PubMed ID: 7790243 [TBL] [Abstract][Full Text] [Related]
14. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Bourhis J; Overgaard J; Audry H; Ang KK; Saunders M; Bernier J; Horiot JC; Le Maître A; Pajak TF; Poulsen MG; O'Sullivan B; Dobrowsky W; Hliniak A; Skladowski K; Hay JH; Pinto LH; Fallai C; Fu KK; Sylvester R; Pignon JP; Lancet; 2006 Sep; 368(9538):843-54. PubMed ID: 16950362 [TBL] [Abstract][Full Text] [Related]
15. Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancer. Dobrowsky W; Naudé J; Widder J; Dobrowsky E; Millesi W; Pavelka R; Grasl C; Reichel M Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):803-6. PubMed ID: 9845100 [TBL] [Abstract][Full Text] [Related]
16. Improved results with accelerated hyperfractionated radiotherapy of advanced head and neck cancer. Leborgne F; Zubizarreta E; Fowler J; Ortega B; Mezzera J; Deus JL; Leborgne JH Int J Cancer; 2000 Apr; 90(2):80-91. PubMed ID: 10814958 [TBL] [Abstract][Full Text] [Related]
17. Advanced head and neck carcinoma in women: treatment outcomes may not improve with accelerated hyperfractionated radiotherapy. Leborgne F; Leborgne JH; Fowler JF; Zubizarreta E; Mezzera J Cancer; 2001 Jun; 91(12):2353-60. PubMed ID: 11413525 [TBL] [Abstract][Full Text] [Related]
18. Accelerated hyperfractionated irradiation with concomitant boost for stage II laryngeal cancer and locally advanced head and neck cancer. Ishii K; Tashiro M; Hosono M; Fukuda H; Takada Y; Kondo S; Inoue Y; Iguchi H; Kusuki M; Yamane H Acta Otolaryngol Suppl; 2004 Oct; (554):62-6. PubMed ID: 15513514 [TBL] [Abstract][Full Text] [Related]
19. [Controlled clinical trials of hyperfractionated and accelerated radiotherapy in otorhinolaryngologic cancers]. Horiot JC Bull Acad Natl Med; 1998; 182(6):1247-60; discussion 1261. PubMed ID: 9812410 [TBL] [Abstract][Full Text] [Related]
20. Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial. Bentzen SM; Saunders MI; Dische S; Bond SJ Radiother Oncol; 2001 Aug; 60(2):123-35. PubMed ID: 11439207 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]